Colony Group, LLC
- SEC CIK
- 0001542153
- Latest filing
- Aug 12, 2026
SGMOQ holding history
Sangamo Therapeutics, Inc in every 13F filed by Colony Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SGMOQ overviewAll 13F holders of SGMOQFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −11,000−100.0% | Sold out | Holders |
| Q1 2026 | 11,000 | $2.72K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 11,000 | $4.62K | <0.1% | −5,300−32.5% | Reduced | Holders |
| Q3 2025 | 16,300 | $10.8K | <0.1% | +1,000+6.5% | Added | Holders |
| Q2 2025 | 15,300 | $8.28K | <0.1% | +1,000+7.0% | Added | Holders |
| Q1 2025 | 14,300 | $9.38K | <0.1% | −900−5.9% | Reduced | Holders |
| Q4 2024 | 15,200 | $15.5K | <0.1% | +15,200 | New | Holders |